Profiel
Elke Bestel worked as the Chief Medical Officer at PregLem SA from 2012 to 2015 and as the VP, Head-Drug Safety & Pharmacovigilance at ObsEva SA from 2019 to 2022.
Dr. Bestel holds a doctorate degree from the University of Gottingen.
Eerdere bekende functies van Elke Bestel
| Bedrijven | Functie | Einde |
|---|---|---|
| OBSEVA SA | Hoofd Techniek/Wetenschap/O&O | 15-07-2019 |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Hoofd Techniek/Wetenschap/O&O | 01-08-2015 |
Opleiding van Elke Bestel
| University of Gottingen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OBSEVA SA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
